Viral Hepatitis and Treponemal Antibody Diagnostic Test Kits

The Florida Department of Health is seeking competitive bids for FDA-approved laboratory-based immunoassays for chronic hepatitis and syphilis Treponemal antibody diagnostic test kits through Invitation to Bid (ITB) DOH24-019. The procurement involves acquiring six new common analyzers to be distributed across public health laboratory locations in Jacksonville, Miami, and Tampa, with estimated annual testing volumes ranging from 4,000 to 17,000 tests across different diagnostic test types. Bid responses are due by May 19, 2025, at 3:30 PM, with an anticipated contract award posting on May 26, 2025. The initial contract term will be one year from March 1, 2025, or the contract execution date, with options for three additional one-year renewals. Bidders must provide comprehensive pricing for six different diagnostic test types, submit detailed technical specifications for test kits, and agree to a reagent rental agreement that includes furnishing proprietary testing equipment at no additional cost. Required certifications include non-collusion, scrutinized companies, forced labor, and foreign countries of concern attestations. Vendors must also demonstrate E-Verify compliance and provide comprehensive maintenance and training provisions for the analyzers.

The procurement does not explicitly indicate specific set-aside designations or restrictions for disadvantaged enterprises. The solicitation appears open to qualified medical diagnostic equipment and test kit providers capable of meeting the technical specifications and compliance requirements. The contract includes a comprehensive equipment provision where the successful vendor will provide analyzers on a rental basis, with equipment to be removed 30 calendar days after the contract term concludes. While specific budget ranges are not definitively stated, the estimated annual testing volumes and requirement for detailed pricing calculations suggest a potentially significant contract value. The multi-year contract structure with consistent pricing across the initial term and potential renewal periods indicates the state's intent to establish a long-term partnership with a qualified diagnostic test kit provider. The geographic distribution of analyzers across three major Florida cities suggests a statewide public health testing strategy focused on viral hepatitis and syphilis diagnostic capabilities.